This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

10 Stocks of Top-Performing Mutual Funds in 2012

5. Arctic Cat (ACAT)

Company profile: Arctic Cat, with a market value of $467 million, designs, engineers, manufactures, and markets snowmobiles and all-terrain vehicles (ATVs) under the Arctic Cat brand name.

Investor takeaway: Its shares are up 42% this year and have a three-year, average annual return of 100%. Analysts give its shares two "buy" ratings, two "buy/holds," and two "holds," according to a survey of analysts by S&P. Analysts estimate it will earn $2.73 per share this fiscal year and rise 24% to $3.38 next year.

4. Sears Holdings (SHLD)

Company profile: Sears Holdings, with a market value of $5.6 billion, is the parent company of Sears, Sears Canada and Kmart stores. It is the fourth-largest broadline retailer in the U.S.

Investor takeaway: Its shares are up 59% this year but have a three-year, average annual decline of 9.8%. Analysts give its shares two "hold," ratings, three "weak holds," and one "sell," according to a survey of analysts by S&P. Analysts estimate it will lose $2.66 in its fiscal 2013 and lose $2.57 in the following year. It is in the process of downsizing and refocusing its efforts, with plans to close over 173 underperforming stores this year.

3. Monster Beverage (MNST)

Company profile: Monster, with a market value of $13 billion, develops, markets, and sells a variety of nonalcoholic beverages, including energy drinks, natural sodas, and fruit juices. Its Monster Energy Drink is the second-largest selling energy drink in the U.S.

Investor takeaway: Its shares are up 62% this year and have a three-year, average annual return of 69%. Analysts give its shares four "buy" ratings, two "buy/holds," four "holds," and one "weak hold," according to a survey of analysts by S&P. Analysts estimate it will earn $2.04 per share this year and $2.51 next year.

2. American Vanguard Corp. (AVD)

Company profile: American Vanguard, with a market value of $736 million, is a specialty chemical manufacturer with a focus on the agricultural and commercial markets.

Investor takeaway: Its shares are up 92% this year and have a three-year, average annual return of 34%. Analysts give its shares one "buy" rating, one "buy/hold," and one "hold," according to a survey of analysts by S&P.

Analysts estimate it will earn $1.06 per share this year and that earnings will grow by 25% to $1.32 next year.

1. Regeneron Pharmaceuticals (REGN)

Company profile: Regeneron, with a market value of $11 billion, is a biotech firm that develops, and commercializes drugs that fight inflammation, cancer, and eye disease.

Investor takeaway: Its shares are up 102% this year and have a three-year, average annual return of 90%. Analysts give its shares seven "buy" ratings, two "buy/holds," and seven "holds," according to a survey of analysts by S&P.

Analysts estimate it will earn $1.25 per share this year and that earnings will grow 105% to $2.56 in 2013.

Stock quotes in this article: MNST, EBAY, CAB, AVD, REGN, ACAT, SHLD, AIG, PII, ALXN 
Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs